FDA



FDA Recent News

Substance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication Drug
FDA Approves Hemp Meal For Hen Feed, NH Eyes Private Cannabis Sales Model, CT Flower Shortage And More
Why Obesity-Drug Maker NeuroBo Stock Is Trading Higher
USDA Intensifies Hemp Industry Analysis With Nationwide Farmer Surveys
FDA Finds No Evidence Weight-Loss Drugs Cause Suicidal Thoughts
Reckitt's Mead Johnson Initiates Massive Recall Of 675K Cans Of Hypoallergenic Baby Formula Over Bacteria Contamination Fears
Charlotte's Web And DeFloria Launch First Ever Hemp-Based Drug Into Human Trials
CBD's Critical Moment: Coalition Pushes For FDA Oversight
Logan Paul Challenges Schumer's Scrutiny Of PRIME's Caffeine Content: 'Why Aren't We Controlling This At The Point Of Purchase?'
Elon Musk's Brain Chip Company Gets FDA Greenlight For 'First-In-Human Clinical Study'
Tesla, Apple, Riot Platforms, AMC, Emergent Biosolutions: Why These 5 Stocks Are Drawing Investors' Attention Today
Elon Musk-Led Neuralink Seeks Collaborators For Human Trials Of Brain-Implanted Chips
Analyst: La Jolla Pharma A Buy Ahead Of February FDA Date
Omeros' OMIDRIA Eye Drop OK'ed For Pediatric Use
FDA Decisions In November: The Month In Review
Ultragenyx Seeks An FDA Win For Biologic Therapy Candidate
At Long Last, Dynavax Wins FDA Approval For Heplisav
Adamas Pharma's Gocovri Will Achieve 'Blockbuster' Status, Says Kerrisdale
Novavax The Downtrodden Finally Finds A New Bull At Citi
Here's Why Exelixis Is Trading Higher By 20%
Momenta Pharma Could Face Pressure Following Approval Of Mylan's Generic Copaxone
U.S. Approval Of PTC Therapeutics' Translarna 'Remains Unlikely'
Canaccord Sticks With Dexcom As Shares Tumble Amid Unexpected Label Addition